![](/img/cover-not-exists.png)
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Fedoriw, Andrew, Rajapurkar, Satyajit R., O'Brien, Shane, Gerhart, Sarah V., Mitchell, Lorna H., Adams, Nicholas D., Rioux, Nathalie, Lingaraj, Trupti, Ribich, Scott A., Pappalardi, Melissa B., Shah,Language:
english
Journal:
Cancer Cell
DOI:
10.1016/j.ccell.2019.05.014
Date:
June, 2019
File:
PDF, 6.93 MB
english, 2019